Heat shock protein 70 inhibits α-synuclein fibril formation via interactions with diverse intermediates

被引:95
作者
Huang, Chunjuan
Cheng, Han
Hao, Shufeng
Zhou, Hui
Zhang, Xujia
Gao, Jianen
Sun, Qi-Hong
Hu, Hongyu
Wang, Chih-chen [1 ]
机构
[1] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China
[3] Beijing Proteome Res Ctr, Beijing 100850, Peoples R China
[4] Beijing Inst Radiat Med, Beijing 100850, Peoples R China
[5] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
asynuclein; fibril; intermediate; heat shock protein 70; chaperone;
D O I
10.1016/j.jmb.2006.08.062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein (AS) is a main component of Lewy bodies in midbrain dopamine neurons pathologically characteristic of Parkinson's disease. We show that heat shock protein (Hsp) 70 inhibits AS fibril formation via preventing the formation of prefibrillar AS (PreAS), binding with PreAS to impede nuclei formation, and binding with nuclei to retard fibril elongation. Also, Hsp70 suppresses the PreAS-induced permeabilization of vesicular membrane through interactions with PreAS. The substrate-binding domain alone is sufficient for Hsp70 to inhibit AS fibril formation. The binding of Hsp70 with PreAS only requires the substrate-binding subdomain, and the binding with AS nuclei requires the C-terminal lid subdomain as well. The results may form the molecular basis for elucidating the mechanism of AS fibril formation and the crucial roles of chaperones in protecting proteins from toxic conversion in many conformational diseases. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:323 / 336
页数:14
相关论文
共 50 条
[1]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[2]   Roles of molecular chaperones in protein misfolding diseases [J].
Barral, JM ;
Broadley, SA ;
Schaffar, G ;
Hartl, FU .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (01) :17-29
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[5]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[6]   Parkinson's disease: Mechanisms and models [J].
Dauer, W ;
Przedborski, S .
NEURON, 2003, 39 (06) :889-909
[7]   Heat shock protein 70 inhibits α-synuclein fibril formation via preferential binding to prefibrillar species [J].
Dedmon, MM ;
Christodoulou, J ;
Wilson, MR ;
Dobson, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (15) :14733-14740
[8]   Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations [J].
Dedmon, MM ;
Lindorff-Larsen, K ;
Christodoulou, J ;
Vendruscolo, M ;
Dobson, CM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (02) :476-477
[9]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398
[10]   Lipid rafts mediate the synaptic localization of α-synuclein [J].
Fortin, DL ;
Troyer, MD ;
Nakamura, K ;
Kubo, S ;
Anthony, MD ;
Edwards, RH .
JOURNAL OF NEUROSCIENCE, 2004, 24 (30) :6715-6723